Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Arcus Ventures | |
Description | ABOUT US TEAM Advisors Portfolio FUND I FUND II EXITS Investment Criteria News Contact Investing in the Future Learn more about Arcus Ventures investment |
Keywords | N/A |
WebSite | arcusventures.com |
Host IP | 209.17.116.6 |
Location | United States |
Site | Rank |
US$1,929,723
Last updated: 2022-07-12 02:32:46
arcusventures.com has Semrush global rank of 5,484,884. arcusventures.com has an estimated worth of US$ 1,929,723, based on its estimated Ads revenue. arcusventures.com receives approximately 222,661 unique visitors each day. Its web server is located in United States, with IP address 209.17.116.6. According to SiteAdvisor, arcusventures.com is safe to visit. |
Purchase/Sale Value | US$1,929,723 |
Daily Ads Revenue | US$1,782 |
Monthly Ads Revenue | US$53,439 |
Yearly Ads Revenue | US$641,262 |
Daily Unique Visitors | 14,845 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
arcusventures.com. | A | 7199 | IP: 209.17.116.6 |
arcusventures.com. | NS | 14400 | NS Record: dns101.register.com. |
arcusventures.com. | NS | 14400 | NS Record: dns102.register.com. |
arcusventures.com. | MX | 14400 | MX Record: 10 arcusventures-com.mail.protection.outlook.com. |
arcusventures.com. | TXT | 14400 | TXT Record: MS=ms40630856 |
arcusventures.com. | TXT | 14400 | TXT Record: v=spf1 ip4:65.204.47.221 ip4:18.217.64.248 ip4:34.212.87.186 include:spf.protection.outlook.com include:custspf.register.com -all |
ABOUT US TEAM Advisors Portfolio FUND I FUND II EXITS Investment Criteria News Contact Investing in the Future Learn more about Arcus Ventures investment criteria. We are dedicated to investing in oncology focused companies Arcus Ventures (AV) consists of a team of professionals with experience in clinical and academic medicine, drug development, hospital management, healthcare industry consulting and private equity. AV is dedicated to investing in oncology focused companies with innovative biopharmaceuticals and/or new drug delivery platforms in development, device companies with products that have pre-marketing approval, and service companies with positive revenue. Recent News Oct 25, 2019 MacroGenics Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in ... Oct 22, 2019 MacroGenics Announces Second Interim Overall Survival Data from Phase 3 SOPHIA Study of ... Sep 25, 2019 T2 Biosystems’ T2Resistance™ Panel is First Diagnostic to Graduate from CARB-X Portfolio © 2018 |
HTTP/1.1 200 OK Cache-Control: private Content-Length: 8080 Content-Type: text/html; charset=utf-8 Server: Microsoft-IIS/10.0 X-AspNet-Version: 4.0.30319 X-Powered-By: ASP.NET X-Powered-By: ARR/3.0 Date: Sun, 31 Oct 2021 15:48:08 GMT |
Domain Name: ARCUSVENTURES.COM Registry Domain ID: 434821423_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.register.com Registrar URL: http://www.register.com Updated Date: 2021-04-03T08:32:39Z Creation Date: 2006-05-03T18:19:15Z Registry Expiry Date: 2025-05-03T18:19:15Z Registrar: Register.com, Inc. Registrar IANA ID: 9 Registrar Abuse Contact Email: abuse@web.com Registrar Abuse Contact Phone: +1.8003337680 Domain Status: ok https://icann.org/epp#ok Name Server: DNS101.REGISTER.COM Name Server: DNS102.REGISTER.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T01:23:34Z <<< |